10 min listen
NEJM Interview: Dr. Jason Schwartz on processes for determining the safety and efficacy of Covid-19 vaccine candidates and for distributing vaccines.
FromNEJM Interviews
NEJM Interview: Dr. Jason Schwartz on processes for determining the safety and efficacy of Covid-19 vaccine candidates and for distributing vaccines.
FromNEJM Interviews
ratings:
Length:
12 minutes
Released:
Oct 28, 2020
Format:
Podcast episode
Description
Jason Schwartz is an assistant professor in the Department of Health Policy and Management at the Yale School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.L. Schwartz. Evaluating and Deploying Covid-19 Vaccines — The Importance of Transparency, Scientific Integrity, and Public Trust. N Engl J Med 2020;383:1703-1705. M. Slaoui and M. Hepburn. Developing Safe and Effective Covid Vaccines — Operation Warp Speed’s Strategy and Approach. N Engl J Med 2020;383:1701-1703. J. Avorn and A.S. Kesselheim. Up Is Down — Pharmaceutical Industry Caution vs. Federal Acceleration of Covid-19 Vaccine Approval. N Engl J Med 2020;383:1706-1708.
Released:
Oct 28, 2020
Format:
Podcast episode
Titles in the series (100)
NEJM Interview: Dr. Allison Goldfine on statins, the associated risk of diabetes, and the FDA's response. by NEJM Interviews